StockMarketWire.com - Benchmark, the aquaculture health, nutrition and breeding and genetics business, has developed specific pathogen resistant shrimp to address issues facing the Asian market, the largest and fastest growing market for shrimp.

The company said it would soon start field trials in the region and would provide an update in due course.

It said: 'This is a breakthrough development which, combined with our leading market position in the industry, creates a very attractive growth opportunity for Benchmark.'


At 9:58am: [LON:BMK] Benchmark Holdings Plc share price was +4.25p at 50.5p



Story provided by StockMarketWire.com